PRINCIPAL CONSULTANT
AMIE PHINNEY, PHD, MBA
A bio-pharmaceutical professional with 20 years of experience delivering collaborative scientific research programs to funding and development milestones. Amie led early drug discovery teams within Solvay Pharmaceutical and Abbot Labs before transitioning to Project/Program/Alliance Management at AbbVie. Amie was the inaugural CSO for a biotech spin-off company, Lakeside Discovery, co-funded by Northwestern University and Deerfield Venture Capital. Amie returned to Canada in 2021, taking on Partnership Management and Business Development roles at Canada's adMare Bioinnovations and Stem Cell Network. Amie holds a PhD in Biomedical Research from the University of Basel in Switzerland, and earned her MBA in 2018.
A biomedical scientist and innovation leader with over a decade's experience at the intersection of science, strategy and commercialization. Most recently, served as Senior Associate & Partnership Manager at adMare BioInnovations, where he played a pivotal role in advancing the commercialization of life sciences innovations, supporting startup growth, and strengthening Canada’s position as a leader in life sciences through technology evaluation, strategic partnerships and ecosystem development. Previously, Chief Scientific Officer at Mazumdar Shaw Center for Translational Research (MSCTR) where he directed the commercialization of a liquid biopsy genetic test suite for early cancer detection, positioning MSCTR at the forefront of non-invasive cancer diagnostics. His postdoctoral research at Cincinnati Children’s Hospital advanced the understanding molecular drivers of AML and pioneered the development of microRNA-targeted therapies. He holds a PhD in Bioengineering from Clemson University and an MBA from John Molson School of Business at Concordia University.
​
​
ADITYA CHAUBEY, PHD, MBA
CONSULTANT
Experienced pharmaceutical professional with a strong background in project and program development, quality control, and GMP-regulated manufacturing environments. Trained as a chemist and molecular biologist, with over a decade of success leading New Product Development projects, QC laboratory operations, method transfers, stability programs, supplier audits, and manufacturing change controls at organizations including AbbVie, Baxter Healthcare, NantPharma, and the University of Toronto. Broad expertise in regulated environments, including CAPA management, Supplier Notifications of Change, and manufacturing change control initiatives, ensuring regulatory compliance and supporting product advancement from early development through commercialization.
MARK LAMBERMON, PHD
CONSULTANT
Life sciences professional with 10+ years of experience in commercialization strategy and partnerships.
PhD in Biochemistry, bridging scientific expertise with business strategy to advance early-stage drug development. Passionate about innovations that improve lives. Skilled in due diligence, market analysis, and stakeholder engagement. Eager to apply my collaborative skills to support strategic decisions and drive therapies that transform patient outcomes.